Statistics
Publications
6
Citations
380
H-Index
6
Active since
2012
Elisa Bergaggio is an author at University of Turin specializing in medicine, oncology, and alk fusion genes.
Publications per year
2012–2023
6
6
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies
Elisa Bergaggio, Chiara Riganti, Giulia Garaffo et al. · Blood · 2018 · 61 citations · Full text
Medicine, Hematology, Oncology +13
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells
Elisa Bergaggio, Wei‐Tien Tai, Andrea Aroldi et al. · Cancer Cell · 2023 · 49 citations · Full text
Medicine, Oncology, Pharmacology +15
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
Inês Mota, Enrico Patrucco, Cristina Mastini et al. · Nature Cancer · 2023 · 42 citations · Full text
Medicine, Immunology, Oncology +14
1–5 of 6